Skip to main content

Share story

Science Robotics

Biodegradable paper battery powers ingestible devices for three days in pigs

A close up of a person wearing a blue shirt with their tongue sticking out and a red and white pill on it Image: Primary
Researchers demonstrated a swallowable paper-like battery that powered medical devices inside pigs for up to three days before its biodegradable components broke down. A small version powered an experimental RFID tag, while a larger one powered a capsule that stimulated the stomach and increased the hormone ghrelin without visible tissue damage at the stimulation site. The layered battery uses a magnesium-alloy anode, a molybdenum-trioxide and activated-carbon cathode, a biodegradable electrolyte and wax coatings that regulate degradation. Capacity remains low, performance varied between units, and the non-biodegradable circuit board passed through the animals rather than dissolving.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Live Science and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...